Peptide Receptor Radionuclide Therapy Medication Savings with TheDrugClub
Discount pricing may be available. Current formulary eligibility is being verified; a condition association does not establish FREE coverage.
- Join TheDrugClub as a member
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available discount pricing
About Peptide Receptor Radionuclide Therapy
Peptide Receptor Radionuclide Therapy (PRRT) represents a significant advancement in treating certain neuroendocrine tumors, delivering targeted radiation directly to cancer cells. While this specialized treatment offers new hope, the accompanying medications and supportive care can be costly. TheDrugClub is here to ease that financial burden, helping you manage prescription expenses so you can prioritize your health and well-being.
Peptide Receptor Radionuclide Therapy (PRRT) is an innovative and highly targeted treatment primarily used for advanced neuroendocrine tumors (NETs), particularly gastroenteropancreatic neuroendocrine tumors (GEP-NETs). This therapy works by using a specially designed molecule – a peptide – that specifically binds to somatostatin receptors, which are often overexpressed on NET cells. This peptide is then linked to a radioactive isotope, such as Lutetium-177.
Once administered, the peptide acts like a homing beacon, guiding the radioactive isotope directly to the tumor cells. The radiation is then delivered precisely to the cancer, minimizing exposure to healthy surrounding tissues. This targeted approach helps to shrink tumors, slow disease progression, and improve quality of life for many patients
The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.